Recent Quotes (30 days)

You have no recent quotes
chg | %

Hercules Capital Inc  

(Public, NYSE:HTGC)   Watch this stock  
Find more results for NASDAQ:HTGC
14.17
-0.10 (-0.70%)
Jan 20 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 14.14 - 14.40
52 week 9.92 - 14.64
Open 14.27
Vol / Avg. 450,042.00/444,375.00
Mkt cap 1.09B
P/E 15.39
Div/yield 0.31/8.75
EPS 0.92
Shares 77.19M
Beta 0.88
Inst. own 44%
Feb 23, 2017
Q4 2016 Hercules Capital Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 7, 2016
Hercules Capital Inc at Wells Fargo Middle Market Opportunities Forum
Nov 29, 2016
Hercules Capital Inc at FBR Investor Conference
Nov 16, 2016
Hercules Capital Inc at Jefferies Business Development Company Summit - Frankfurt
Nov 16, 2016
Hercules Capital Inc at Jefferies Business Development Company Summit - Zurich
Nov 15, 2016
Hercules Capital Inc at Jefferies Business Development Company Summit - London
Nov 3, 2016
Q3 2016 Hercules Capital Inc Earnings Call - Webcast
Nov 3, 2016
Q3 2016 Hercules Capital Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 68.32% 27.31%
Operating margin 52.72% 46.78%
EBITD margin - 46.90%
Return on average assets 8.78% 3.27%
Return on average equity 16.59% 6.02%
Employees 63 -
CDP Score - -

Address

400 Hamilton Ave Ste 310
PALO ALTO, CA 94301-1805
United States - Map
+1-650-2893060 (Phone)
+1-650-4739194 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hercules Capital, Inc., formerly Hercules Technology Growth Capital, Inc., is a specialty finance company. The Company is focused on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences and sustainable and renewable technology industries. The Company is an internally managed, non-diversified, closed-end investment company. The Company focuses its investments in companies active in the technology industry sub-sectors characterized by products or services, including computer software and hardware; networking systems; semiconductors; semiconductor capital equipment; information technology infrastructure or services; Internet consumer and business services; telecommunications; telecommunications equipment, and media. Within the life science sub-sector, the Company focuses on medical devices, bio-pharmaceutical, drug discovery, drug delivery, healthcare services and information systems companies.

Officers and directors

Manuel A. Henriquez Chairman of the Board, President, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark Robert Harris CPA Chief Financial Officer
Age: 45
Bio & Compensation  - Reuters
Scott Bluestein Chief Investment Officer
Age: 36
Bio & Compensation  - Reuters
Melanie Grace Chief Compliance Officer, General Counsel
Age: 46
Bio & Compensation  - Reuters
Andrew Olson Vice President - Finance, Senior Controller
Age: 32
Bio & Compensation  - Reuters
Jennifer McKay Vice President of Human Resources
Bio & Compensation  - Reuters
Allyn C. Woodward Jr. Lead Independent Director
Age: 74
Bio & Compensation  - Reuters
Doreen Woo Ho Director
Age: 68
Bio & Compensation  - Reuters
Robert P. Badavas Independent Director
Age: 62
Bio & Compensation  - Reuters
Thomas J. Fallon Independent Director
Age: 54
Bio & Compensation  - Reuters